- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Novel Human Topoisomerase I Inhibitors, Topopyrones A, B, C and D. II. Structure Elucidation.
-
- ISHIYAMA DAISUKE
- Metabolism Research, Kaken Pharmaceutical CO., LTD.
-
- KANAI YOSHINORI
- Institute of Biotechnology Applied to Soil Eumycetes
-
- SENDA HISATO
- Metabolism Research, Kaken Pharmaceutical CO., LTD.
-
- IWATANI WAKAO
- Metabolism Research, Kaken Pharmaceutical CO., LTD.
-
- TAKAHASHI HIROKO
- Institute of Biotechnology Applied to Soil Eumycetes
-
- KONNO HIROSHI
- Institute of Biotechnology Applied to Soil Eumycetes
-
- KANAZAWA SUSUMU
- Institute of Biotechnology Applied to Soil Eumycetes
Bibliographic Information
- Other Title
-
- II. Structure Elucidation
Search this article
Description
The structures of novel topoisomerase I inhibitors, topopyrones A, B, C and D were elucidated by spectral analysis of the chemical derivatives. These compounds are an anthraquinone type containing a fused 1, 4-pyrone moiety. Topopyrones A and B contain a chlorine atom, however C and D do not. It was suggested that topopyrones B and D are converted from topopyrones A and C, respectively by Wessely-Moser type rearrangement.
Journal
-
- The Journal of Antibiotics
-
The Journal of Antibiotics 53 (9), 873-878, 2000
JAPAN ANTIBIOTICS RESEARCH ASSOCIATION
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679128227712
-
- NII Article ID
- 130003503787
-
- COI
- 1:CAS:528:DC%2BD3cXntVanurY%3D
-
- ISSN
- 18811469
- 00218820
-
- PubMed
- 11099219
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed